Log in to save to my catalogue

Development and Evaluation of Cannabidiol Orodispersible Tablets Using a 23-Factorial Design

Development and Evaluation of Cannabidiol Orodispersible Tablets Using a 23-Factorial Design

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_fd47e5651f6143a39366ed86dbc694c9

Development and Evaluation of Cannabidiol Orodispersible Tablets Using a 23-Factorial Design

About this item

Full title

Development and Evaluation of Cannabidiol Orodispersible Tablets Using a 23-Factorial Design

Publisher

Basel: MDPI AG

Journal title

Pharmaceutics, 2022-07, Vol.14 (7), p.1467

Language

English

Formats

Publication information

Publisher

Basel: MDPI AG

More information

Scope and Contents

Contents

Orodispersible tablets (ODTs) are pharmaceutical formulations used to obtain fast therapeutic effects, usually recommended for geriatric and pediatric patients due to their improved compliance, bioavailability, ease of administration, and good palatability. This study aimed to develop ODTs with cannabidiol (CBD) phytocannabinoid extracted from Cann...

Alternative Titles

Full title

Development and Evaluation of Cannabidiol Orodispersible Tablets Using a 23-Factorial Design

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_fd47e5651f6143a39366ed86dbc694c9

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_fd47e5651f6143a39366ed86dbc694c9

Other Identifiers

ISSN

1999-4923

E-ISSN

1999-4923

DOI

10.3390/pharmaceutics14071467

How to access this item